Timing | Immediately Preop (N = 211) | Postop (N = 209) Mean Days = 27 | Postop (N = 198) Mean Days = 776 | Preop Vs. First F/U T-Test P-Value | Preop Vs. Last F/U T-Test P-Value | First F/U Vs. Last F/U P-Value |
---|---|---|---|---|---|---|
MR | ||||||
No/Trace | 44.1% (N = 93) | 89% (N = 186) | 82.8% (N = 113) | |||
Mild | 13.7% (N = 29) | 6.2% (N = 13) | 11.1% (N = 22) | <0.0001 | <0.0001 | 0.3173 |
Moderate | 16.1% (N = 34) | 1% (N = 2) | 2.5% (N = 5) | |||
Severe | 26.1% (N = 55) | 3.8% (N = 8) | 3.5% (N = 7) | |||
MS | ||||||
No | 73.9% (N = 156) | 99.5% (N = 208) | 98.5% (N = 195) | |||
Mild | 2.4% (N = 5) | 0.5% (N = 1) | 1.5% (N = 3) | <0.0001 | <0.0001 | - |
Moderate | 3.3% (N = 7) | - | - | |||
Severe | 20.4% (N = 43) | - | - | |||
TR | ||||||
No/Trace | 24.7% (N = 52) | 47.4% (N = 99) | 38.9% (N = 77) | |||
Mild | 25.6% (N = 54) | 26.8% (N = 56) | 24.8% (N = 49) | <0.0001 | 0.0009 | 0.029 |
Moderate | 28.4% (N = 60) | 20.1% (N = 42) | 25.8% (N = 51) | |||
Severe | 21.3% (N = 45) | 5.7% (N = 12) | 10.6% (N = 21) | |||
TS | ||||||
No/Trace | 96.7% (N = 204) | 99.5% (N = 208) | 99% (N = 196) | |||
Mild | 1% (N = 2) | 0.5% (N = 1) | 0.5% (N = 1) | 0.0253 | 0.1025 | 0.3173 |
Moderate | 1.4% (N = 3) | 0.5% (N = 1) | ||||
Severe | 1% (N = 2) | |||||
AR | ||||||
No/Trace | 63.5% (N = 134) | 74.2% (N = 155) | 70.2% (N = 139) | |||
Mild | 16.6% (N = 35) | 17.2% (N = 36) | 15.7% (N = 31) | 0.0003 | 0.0833 | 0.0499 |
Moderate | 13.3% (N = 28) | 6.7% (N = 14) | 12.1% (N = 24) | |||
Severe | 6.6% (N = 14) | 1.9% (N = 4) | 2% (N = 4) | |||
AS | ||||||
No | 88.6% (N = 187) | 95.2% (N = 199) | 92.4% (N = 183) | |||
Mild | 5.7% (N = 12) | 3.4% (N = 7) | 4.6% (N = 9) | 0.0225 | 0.1967 | 0.3173 |
Moderate | 2.4% (N = 5) | 1.4% (N = 3) | 2% (N = 4) | |||
Severe | 3.3% (N = 7) | 1% (N = 2) | ||||
LV | ||||||
Function | ||||||
Normal | 58.3% (N = 123) | 52.2% (N = 109) | 49% (N = 97) | 0.0053 | 0.0000 | 00027 |
Mild | 32.7% (N = 69) | 32.1% (n = 67) | 32.8% (N = 65) | |||
Moderate | 7.1% (N = 15) | 6.2% (N = 13) | 15.2% (N = 30) | |||
Severe | 1.9% (N = 4) | 9.6% (N = 20) | 8.1% (N = 16) | |||
RV | ||||||
Function | ||||||
Normal | 48.8% (N = 103) | 34.5% (N = 72) | 49% (N = 97) | <0.0001 | 0.0113 | 0.0039 |
Mild | 32.2% (N = 68) | 30.1% (N = 63) | 26.8% (N = 53) | |||
Moderate | 15.6% (N = 33) | 22% (n = 46) | 17.2% (N = 34) | |||
Severe | 3.3% (N = 7) | 13.4% (N = 28) | 7.1% (N = 14) | |||
Pulmonary | 47.4% (N = 100) | 37.3% (N = 78) | 34.7% (N = 69) | 0.3173 | ||
HTN | 43±19.6 (Range 25-115) | 37.4±15.7 (Range 25-75) | 36.1±14.5 (Range 25–75) | 0.0004 | <0.0001 | (0.2343) |